Free Trial
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free DTIL Stock Alerts

Precision BioSciences (DTIL) Stock Forecast & Price Target

Precision BioSciences logo
$7.27 -0.84 (-10.36%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$7.60 +0.33 (+4.53%)
As of 05/15/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Precision BioSciences - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy
Based on 4 Analyst Ratings
Sell
1
Hold
0
Buy
3

Based on 4 Wall Street analysts who have issued ratings for Precision BioSciences in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 4 analysts, 1 has given a sell rating, and 3 have given a buy rating for DTIL.

Consensus Price Target

$36.33
399.77% Upside
According to the 4 analysts' twelve-month price targets for Precision BioSciences, the average price target is $36.33. The highest price target for DTIL is $60.00, while the lowest price target for DTIL is $19.00. The average price target represents a forecasted upside of 399.77% from the current price of $7.27.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for DTIL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Precision BioSciences and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DTIL Analyst Ratings Over Time

TypeCurrent Forecast
5/17/25 to 5/17/26		1 Month Ago
4/17/25 to 4/17/26		3 Months Ago
2/16/25 to 2/16/26		1 Year Ago
5/17/24 to 5/17/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$36.33$36.33$60.00$47.00
Forecasted Upside399.77% Upside361.08% Upside1,442.42% Upside897.88% Upside
Consensus RatingModerate BuyModerate BuyHoldBuy

DTIL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DTIL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Precision BioSciences Stock vs. The Competition

TypePrecision BioSciencesMedical CompaniesBroader Market
Consensus Rating Score
2.50
2.30
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside399.77% Upside1,822.52% Upside17.90% Upside
News Sentiment Rating
Positive News

See Recent DTIL News
Positive News
Positive News
Export
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside		Details
5/8/2026
Weiss Ratings logo
Weiss Ratings
Not Rated
 UpgradeSell (E+) ➝ Sell (D-)
4/17/2026
JonesTrading logo
JonesTrading
3 of 5 stars
Catherine Novack
Catherine Novack
Not Rated
Reiterated RatingBuy$30.00+290.12%
3/13/2026
Jefferies Financial Group Inc. logo
Jefferies Financial Group
2 of 5 stars
Maury Raycroft
Not Rated
Reiterated RatingBuy$19.00+235.10%
5/21/2025
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Patrick Trucchio
Patrick Trucchio
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
Reiterated RatingBuy$60.00 ➝ $60.00+1,129.51%
1/10/2025
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Kostas Biliouris
Kostas Biliouris
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$34.00 ➝ $34.00+655.55%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 02:46 PM ET.


DTIL Forecast - Frequently Asked Questions

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Precision BioSciences is $36.33, with a high forecast of $60.00 and a low forecast of $19.00.

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Precision BioSciences in the last year. There is currently 1 sell rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" DTIL shares.

According to analysts, Precision BioSciences's stock has a predicted upside of 399.77% based on their 12-month stock forecasts.

Over the previous 90 days, Precision BioSciences's stock had 1 upgrade by analysts.

Precision BioSciences has been rated by research analysts at Jefferies Financial Group, JonesTrading, and Weiss Ratings in the past 90 days.

Analysts like Precision BioSciences more than other "medical" companies. The consensus rating for Precision BioSciences is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how DTIL compares to other companies.

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Precision BioSciences Recommendations


This page (NASDAQ:DTIL) was last updated on 5/17/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
SpaceX Goes Public. Here's What Happens To Your IRA.
When SpaceX goes public, fund managers will sell existing portfolio holdings to fund the move. Trillions in as...
Americas Gold Company | Sponsoredtc pixel